CN Patent

CN102070606A — 一种雷利度胺a晶型新的制备方法

Assigned to Jiangsu Simcere Pharmaceutical R&D Co Ltd · Expires 2011-05-25 · 15y expired

What this patent protects

本发明提供了一种LenalidomideA晶型的制备方法，即将Lenalidomide悬浮于异丁醇、异丙醇与二氯甲烷一种或多种溶剂中，然后搅拌结晶，得到上述LenalidomideA晶型。

USPTO Abstract

本发明提供了一种LenalidomideA晶型的制备方法，即将Lenalidomide悬浮于异丁醇、异丙醇与二氯甲烷一种或多种溶剂中，然后搅拌结晶，得到上述LenalidomideA晶型。

Drugs covered by this patent

Patent Metadata

Patent number
CN102070606A
Jurisdiction
CN
Classification
—
Expires
2011-05-25
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Simcere Pharmaceutical R&D Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.